Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide Repeat Diseases

NCT04529252 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT04529252
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04529252 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide Repeat Diseases
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Active, not recruiting
Start date
July 17, 2017
Completion date
December 31, 2026
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebellar ataxia, nucleotide repeat disease, spinocerebellar ataxias